Tag Archives: Oral Dose

Carbidopa-levodopa-entacapone

U.S. BRAND NAMES — Stalevo® PHARMACOLOGIC CATEGORY Anti-Parkinson’s Agent, COMT Inhibitor Anti-Parkinson’s Agent, Dopamine Agonist DOSING: ADULTS Note: All strengths of Stalevo® contain a carbidopa/levodopa ratio of 1:4 plus entacapone 200 mg. Parkinson’s disease: Oral: Dose should be individualized based on therapeutic … Continue reading

Posted in Drug Information | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off